» Articles » PMID: 7503768

Differentiation Between Partial and Silent 5-HT1D Beta Receptor Antagonists Using Rat C6-glial and Chinese Hamster Ovary Cell Lines Permanently Transfected with a Cloned Human 5-HT1D Beta Receptor Gene

Overview
Date 1995 Nov 9
PMID 7503768
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Intrinsic activities of serotonin (5-HT) receptor ligands at cloned human 5-HT1D beta receptor sites were determined by measuring cAMP responses in two permanently transfected cell types: rat C6-glial and Chinese hamster ovary (CHO)-K1 cells. Both transfected cell lines expressed a similar 5-HT1D beta receptor density (361 to 448 fmol/mg protein) and displayed a number of similar cAMP responses: marked inhibition of forskolin-stimulated cAMP formation by 5-HT; a similar agonist potency and efficacy with 5-carboxamidotryptamine (5-CT), 5-methoxytryptamine, bufotenine, sumatriptan, 7-trifluoromethyl-4(4-methyl-1-piperazinyl)-pyrolo-(1,2-a)quinoxal ine (CGS 12066B), 5-methoxy-3(1,2,3,6-tetrahydro-4-pyridinyl)1H-indole (RU 24,969), and tryptamine, their maximal effect being comparable to that of 5-HT; less agonist efficacy with m-trifluoro-phenyl-piperazine (TFMPP) (it inhibited at most 63% of stimulated cAMP formation); and antagonist activity against the 5-CT-mediated agonist response with methiothepin, 2'-methyl-4-(5-methyl-[1,2,4]oxadiazol-3-yl)-biphenyl-4-carboxylic acid [4-methoxy-3-(4-methyl-piperazin-1-yl)-phenyl]-amide (GR 127,935), and ritanserin. Metergoline and 1-naphtylpiperazine showed different intrinsic activities. In contrast to their pronounced antagonist activity in the transfected CHO-K1 cell line, the antagonist effect was only partial and absent for metergoline and 1-naphtylpiperazine in the transfected C6-glial cell line, respectively. In conclusion, these cell lines are useful as a tool to measure with high sensitivity differences in intrinsic activities of 5-HT receptor ligands and, therefore, discriminate between silent antagonists (no intrinsic activity) and antagonists with intrinsic activity (i.e. partial agonists), even though this intrinsic activity may be relatively weak.

Citing Articles

Efficacy of selective 5-HT6 receptor ligands determined by monitoring 5-HT6 receptor-mediated cAMP signaling pathways.

Romero G, Sanchez E, Pujol M, Perez P, Codony X, Holenz J Br J Pharmacol. 2006; 148(8):1133-43.

PMID: 16865095 PMC: 1752021. DOI: 10.1038/sj.bjp.0706827.


Pharmacology of cloned human 5-HT1D receptor-mediated functional responses in stably transfected rat C6-glial cell lines: further evidence differentiating human 5-HT1D and 5-HT1B receptors.

Pauwels P, Palmier C, Wurch T, Colpaert F Naunyn Schmiedebergs Arch Pharmacol. 1996; 353(2):144-56.

PMID: 8717154 DOI: 10.1007/BF00168751.